Scientists may have found a way to prevent statin muscle pain

Millions of individuals rely on statins to manage cholesterol levels and lower the risk of heart attacks or strokes. However, for certain patients, these medications can lead to muscle pain, weakness, and difficulties with physical activities, making adherence to treatment challenging. Researchers at McMaster University have uncovered a potential mechanism behind these muscle-related side effects, which could ultimately pave the way for more tolerable statins without compromising their vital cardiovascular advantages. The study's results are set to be published in Science Advances.

The discovery reveals an unforeseen link between the immune system and muscle cell metabolism, which contributes to muscle damage induced by statins. This finding contrasts with previous assumptions about the origins of these adverse effects. Jonathan Schertzer, a professor in McMaster's Department of Biochemistry and Biomedical Sciences and the study's senior author, emphasizes the significance of these results.

He highlights that although statins are highly effective in reducing cardiovascular disease risk, muscle-related side effects often compel some individuals to reduce their dosage or discontinue the medication altogether.

An estimated seven to 29 percent of statin users experience muscle-related symptoms. Despite the known connection between statins and muscle issues for years, researchers have not comprehensively understood the underlying biological processes. The study, led by first authors Nazli Robin and Nicole Barra of the Schertzer Lab at McMaster, discovered that statins disrupt the way muscle cells generate energy.

This disruption triggers an immune response inside the muscle cells, resulting in tissue damage. By employing experiments with muscle cells and mouse models, the researchers were able to mitigate most of the damage by inhibiting the immune response.

One of the most significant findings of the research is that the mechanism causing muscle side-effects is distinct from the mechanism responsible for lowering cholesterol. This distinction suggests that it may eventually be possible to address the side-effects independently of the cholesterol-lowering effects, potentially making statins more tolerable for patients without diminishing their valuable cardiovascular benefits.

The study also sheds light on the surprising connection between metabolism and the immune system. Changes in muscle cell energy processing trigger the cells' immune response, offering new insights into how inflammation might contribute to medication side effects. Furthermore, targeting the immune pathway could potentially safeguard muscle tissue without affecting statins' cholesterol-lowering effects.

Additional research is required to translate these findings into clinical treatments; however, the newly identified pathway presents multiple potential targets for medications aimed at preventing statin intolerance. These findings enhance our understanding of why some patients experience muscle symptoms and offer promising avenues for enhancing the safety and efficacy of these essential medications in the future.